Free shipping on orders over $300
Order Online 24/7
Register Now Contact Us
Needle

Safety Pen Needle Embecta BD AutoShield Duo Single Use 30G x 5mm

SKU: NOV10019389 ● In Stock
UNIT: BOX 100
$143.66
Inc. GST: $158.03

Dual-shield safety pen needle for ultra-safe, low-pain and precision insulin delivery.

Proceed To Checkout
✓ In Stock — Ready to Ship
Free shipping over $300 Dispatch 1–2 business days Secure checkout +61 0426 379 786

Embecta BD AutoShield Duo 30G x 5mm Safety Pen Needles are sterile, single-use devices engineered for safe and comfortable insulin administration. Featuring dual-ended automatic shielding, they protect both the patient and healthcare provider by reducing needlestick injury risk and preventing exposure after use

You May Also Need

Related Products

NEEDLES 21Gx25mm – Box/100

* Product image is for reference only

Needle NEEDLES 21Gx25mm – Box/100 SKU: NOV10019412
$7.94 Inc. GST: $8.74
Hot
Terumo AGANI Hypodermic Needles 25G x 16mm (Orange) – Box/100

* Product image is for reference only

Needle Terumo AGANI Hypodermic Needles 25G x 16mm (Orange) – Box/100 SKU: NOV10009715
$4.24 Inc. GST: $4.66
BD PrecisionGlide Hypodermic Needles 21Gx38mm – Box/100

* Product image is for reference only

Needle BD PrecisionGlide Hypodermic Needles 21Gx38mm – Box/100 SKU: NOV10019413
$7.94 Inc. GST: $8.74
Hot
BD Ultra-Fine Insulin Syringe, 6mm x 31G 0.3mL – Box/100

* Product image is for reference only

Needle BD Ultra-Fine Insulin Syringe, 6mm x 31G 0.3mL – Box/100 SKU: NOV10019381
$41.99 Inc. GST: $46.19

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by